Zero Candida Announces First Intellectual Property in South Africa

Company is in the process to be listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars

TEL AVIV, IsraelJune 18, 2024 /CNW/ — Zero Candida (the “Company” or “ZC “) an Israeli FemTech medical device start-up is pleased to announce its first INTELLECTUAL PROPERTY – 2022/09265 Granted + PCT patent PCT-IL 2023050243 in South Africa.

Are you an angel?

Public Announcements

Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights

VANCOUVER, BC, April 2, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device…

Zero Candida Commences Trading on OTCQB Market

VANCOUVER, BC, March 12, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device…

Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030

VANCOUVER, BC, Feb. 3, 2025 /PRNewswire/ — A market analysis made by Moore Financial Consulting published today estimate the global market for Zero Candida Technologies,…